Nelson Advisors have accepted an invitation to present to the Healthcare Club at the IESE Business School, Barcelona in December 2025. The Founding Partners of Nelson Advisors believe strongly in sharing their experiences and knowledge of the HealthTech and MedTech markets with students across a wide range of UK and European Universities ranging from Oxford University and University of Cambridge to London Business School and University College London Global Business Schood fo

Nelson Advisors Partner Lloyd Price has been invited to Judge the PitchFest Awards at ReWired 2026. This is the 3rd time Lloyd has Judged the prestigious awards, highlighting the pedigree of UK Digital Health and MedTech companies.

The advisory landscape for European Medical Technology (MedTech) Mergers and Acquisitions (M&A) is distinguished by a structural bifurcation across transactional size and specialised focus. The market influence is segmented into three distinct classes: Tier 1 Global Banks, which dominate based on aggregate transaction value due to their capacity to underwrite and execute multi-billion-dollar strategic acquisitions; Tier 2 Integrated Firms, which drive high deal volume and pro

The UK HealthTech mergers and acquisitions (M&A) market in 2025 is characterised by a "cautious yet discernible rebound". While global digital health funding has seen a decline, the European market, particularly within the UK, has demonstrated remarkable resilience, defying global trends with a significant surge in deal activity. This momentum is not uniform, however; it is marked by a profound bifurcation that separates the market into two distinct categories.

Nelson Advisors invited to Judge the MedTech Startup Pitch Awards at MedTech Europe 2025. The MedTech Malta Startup Pitch is a platform for medical technology startups to showcase their innovative products, services, and solutions to a panel of judges and potential investors. This shall provide a unique opportunity for entrepreneurs to gain exposure, receive feedback, and secure funding for their ventures.

Ambient Voice Technology in the UK: Research Series by Nelson Advisors. The Accelerating UK NHS Ambient Voice Technology Market: Dynamics, Key Players, and Strategic Imperatives report. Ambient Voice Technology and the NHS 10 Year Plan: Strategy, Future Applications, Key Suppliers, Funding and Regulatory Landscape. NHS Ambient Voice Technology Market Heats Up in the UK - key players include TORTUS AI, Heidi Health, ClinicLetter.ai, Scribetech, Suki, Nuance, Tandem.

Lloyd Price, partner at HealthTech M&A firm Nelson Advisors, said the London results were encouraging on that front also. He said: “One of the biggest takeaways from the GOSH trial is the high level of public comfort and consent rate to using ambient voice technologies. To generate all of the productivity and efficiency gains, patients/carers/parents need to agree to being recorded and transcribed. Without high levels of public trust, technology solutions will struggle to be

The relationship between medical technology (MedTech) and defence technology has historically been characterised by an ad hoc, one-directional flow of innovation, often described as a "spin-out" effect where military research unexpectedly finds civilian applications. However, a contemporary analysis reveals a more complex, mutually beneficial, and increasingly institutionalized symbiosis. This interdependence is no longer a matter of serendipitous discovery but a deliberate,

The landscape of business education in Europe is undergoing a fundamental transformation, with HealthTech emerging as a critical nexus of innovation, capital, and leadership. This analysis posits that the traditional metrics of institutional prestige, while important, no longer provide a complete picture for prospective students and industry partners. A more granular, and ultimately more valuable, evaluation necessitates an in-depth examination of a school's specific HealthTe

This report provides a detailed analysis of Nelson Advisors, a highly specialised mergers and acquisitions (M&A), partnerships and investment advisory firm. The firm is exclusively dedicated to the dynamic European medical technology (MedTech) sector, with an extended reach into the UK and North America. The analysis reveals that the firm's primary competitive advantage is rooted in its unique "Founders for Founders" approach, which is underpinned by the direct entrepreneuria

Nelson Advisors Partner Lloyd Price invited to speak on the Investor Forum at the Global Health Exhibition 2025 in Riyadh, Saudi Arabia #GHE25 . The Investor Forum at the Global Health Exhibition 2025 is a premier platform for investors, innovators, and healthcare leaders to explore transformative investment opportunities in Saudi Arabia’s rapidly evolving healthcare landscape.

Nelson Advisors partner Lloyd Price interviewed by Digital Health for their 'NHS App to unleash its full potential' story. Lloyd Price, partner at Nelson Advisors and health tech founder, said that the NHS App needs a “killer feature” to increase its usage and “unlock further organic and viral growth”. He added that the main functions of the NHS App to book GP appointments and order repeat prescriptions can be done through other apps such as Patient Access from EMIS, MyGP fr

Nelson Advisors Partner Lloyd Price has been invited to Judge the 'HealthInvestor Power List 2025 Awards' recognising the most effective, inspiring and influential leaders in Health and Social Care.

Nelson Advisors Partner Lloyd Price will lead the 'HealthTech M&A and IPOs Panel' at the Global Health Exhibition 2025 in Riyadh, Saudi Arabia. #GHE25 The Global Health Exhibition in Riyadh is a major event focused on healthcare innovation, investment, and transformation. It brings together global leaders from both the public and private sectors to discuss the future of healthcare.

Nelson Advisors Partner Lloyd Price joins the new Silver Buck Advisory Board alongside Senior NHS England staff and Former Secretary of State for Health and Social Care.